Avantor, Inc. Proceeds from Long-Term Debt Issued
Avantor, Inc. (AVTR) reported Proceeds from Long-Term Debt Issued of $1.11 billion for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-11.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2026-02-11
- Avantor, Inc. proceeds from issuance of long-term debt for the quarter ending 2025-12-31 was $1.04B.
- Avantor, Inc. proceeds from issuance of long-term debt for the quarter ending 2025-09-30 was $67.70M.
- Avantor, Inc. proceeds from issuance of long-term debt for the quarter ending 2025-06-30 was $0.00.
- Avantor, Inc. proceeds from issuance of long-term debt for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- Avantor, Inc. proceeds from issuance of long-term debt for fiscal 2025 was $1.11B.
- Avantor, Inc. proceeds from issuance of long-term debt for fiscal 2024 was $0.00.
- Avantor, Inc. proceeds from issuance of long-term debt for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Avantor, Inc. proceeds from issuance of long-term debt for fiscal 2022 was $327.20M, a 88.46% decline from fiscal 2021.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 6 month | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 12 month |
|---|---|---|---|---|
| 2025-12-31 | $1.04B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $1.11B derived: sum of 2 quarters · filed 2026-02-11 | $1.11B derived: sum of 3 quarters · filed 2026-02-11 | $1.11B 10-K · filed 2026-02-11 |
| 2025-09-30 | $67.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $67.70M derived: sum of 2 quarters · filed 2025-10-29 | $67.70M 10-Q · filed 2025-10-29 | $67.70M derived: sum of 4 quarters · filed 2026-02-11 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $0.00 10-Q · filed 2025-08-01 | $0.00 derived: sum of 3 quarters · filed 2026-02-11 | -$12.30M derived: sum of 4 quarters · filed 2026-02-11 |
| 2025-03-31 | $0.00 10-Q · filed 2025-04-25 | $0.00 derived: sum of 2 quarters · filed 2026-02-11 | -$12.30M derived: sum of 3 quarters · filed 2026-02-11 | -$41.20M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | -$12.30M derived: sum of 2 quarters · filed 2026-02-11 | -$41.20M derived: sum of 3 quarters · filed 2026-02-11 | $0.00 10-K · filed 2026-02-11 |
| 2024-09-30 | -$12.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | -$41.20M derived: sum of 2 quarters · filed 2025-10-29 | $0.00 10-Q · filed 2025-10-29 | $0.00 derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-06-30 | -$28.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $12.30M 10-Q · filed 2025-08-01 | $12.30M derived: sum of 3 quarters · filed 2026-02-11 | $12.30M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-03-31 | $41.20M 10-Q · filed 2025-04-25 | $41.20M derived: sum of 2 quarters · filed 2026-02-11 | $41.20M derived: sum of 3 quarters · filed 2026-02-11 | $41.20M derived: sum of 4 quarters · filed 2026-02-11 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $0.00 derived: sum of 2 quarters · filed 2026-02-11 | $0.00 derived: sum of 3 quarters · filed 2026-02-11 | $0.00 10-K · filed 2026-02-11 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-27 | $0.00 derived: sum of 2 quarters · filed 2024-07-26 | $0.00 10-Q · filed 2023-10-27 | $82.20M derived: sum of 4 quarters · filed 2025-02-07 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-26 | $0.00 10-Q · filed 2024-07-26 | $82.20M derived: sum of 3 quarters · filed 2025-02-07 | $117.20M derived: sum of 4 quarters · filed 2025-02-07 |
| 2023-03-31 | $0.00 10-Q · filed 2024-04-26 | $82.20M derived: sum of 2 quarters · filed 2025-02-07 | $117.20M derived: sum of 3 quarters · filed 2025-02-07 | |
| 2022-12-31 | $82.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-07 | $117.20M derived: sum of 2 quarters · filed 2025-02-07 | $327.20M 10-K · filed 2025-02-07 | |
| 2022-09-30 | $35.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-27 | $245.00M 10-Q · filed 2023-10-27 | ||
| 2022-06-30 | $210.00M 10-Q · filed 2023-07-28 | |||
| 2021-12-31 | $1.70B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $1.70B derived: sum of 2 quarters · filed 2024-02-14 | $2.83B 10-K · filed 2024-02-14 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | $1.13B 10-Q · filed 2022-10-28 | ||
| 2021-06-30 | $1.13B 10-Q · filed 2022-07-29 | |||
| 2020-12-31 | $1.94B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $3.94B derived: sum of 2 quarters · filed 2023-02-14 | $3.94B derived: sum of 3 quarters · filed 2023-02-14 | $3.94B 10-K · filed 2023-02-14 |
| 2020-09-30 | $2.00B derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29 | $2.00B derived: sum of 2 quarters · filed 2021-10-29 | $2.00B 10-Q · filed 2021-10-29 | $2.00B derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $0.00 10-Q · filed 2021-07-30 | $1.30M derived: sum of 3 quarters · filed 2022-02-11 | -$152.70M derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-03-31 | $0.00 10-Q · filed 2020-04-29 | $1.30M derived: sum of 2 quarters · filed 2022-02-11 | -$152.70M derived: sum of 3 quarters · filed 2022-02-11 | -$2.30M derived: sum of 4 quarters · filed 2022-02-11 |
| 2019-12-31 | $1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-11 | -$152.70M derived: sum of 2 quarters · filed 2022-02-11 | -$2.30M derived: sum of 3 quarters · filed 2022-02-11 | $1.30M 10-K · filed 2022-02-11 |
| 2019-09-30 | -$154.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-27 | -$3.60M derived: sum of 2 quarters · filed 2020-10-27 | $0.00 10-Q · filed 2020-10-27 | |
| 2019-06-30 | $150.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | $154.00M 10-Q · filed 2020-07-29 | ||
| 2019-03-31 | $3.60M 10-Q · filed 2020-04-29 | |||
| 2018-12-31 | $35.70M 10-K · filed 2021-02-16 | |||
| 2018-06-30 | $0.00 10-Q · filed 2019-08-06 | |||
| 2017-12-31 | $9.25B 10-K · filed 2020-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |